News | May 11, 2024
Piramal Pharma posts Q1 FY24 consolidated PAT at Rs. 101.27 Cr
Piramal Pharma has reported total income of Rs. 2,578.74 crores during the period ended March 31, 2024
Piramal Pharma has reported total income of Rs. 2,578.74 crores during the period ended March 31, 2024
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.8.29 crores for the Financial Year ended March 31, 2024
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024
Investing in Malaysia's largest clinic operator to expand the healthcare business
The Unit currently caters to emerging markets of Latin America and Africa with a variety of dosage forms
ORACEA is a trademark of Galderma Holdings, S.A.
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
Subscribe To Our Newsletter & Stay Updated
